SCHEMBL5612431

SCHEMBL5612431

C=CCCCCCCCCC(=O)CCCCCCC=C

nearest known ligand 0.70

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.70
ABCC4 O15439 1/20 0.70
ALDH1A1 P00352 4/20 0.59
LMNA P02545 2/20 0.59
TSHR P16473 3/20 0.46
LPAR3 Q9UBY5 2/20 0.43
LPAR2 Q9HBW0 1/20 0.43
CYP3A4 P08684 3/20 0.42
SMN1; SMN2 Q16637 3/20 0.42
USP2 O75604 2/20 0.42
RECQL P46063 1/20 0.42
FAAH O00519 2/20 0.41
KMT2A Q03164 2/20 0.39
HPGD P15428 1/20 0.37
TRPA1 O75762 1/20 0.37
MEN1 O00255 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5363934 1.00 MAPT (0.70) MAPTABCC4ALDH1A1LMNATSHR
SCHEMBL3170373 1.00 MAPT (0.70) MAPTABCC4ALDH1A1LMNATSHR
SCHEMBL3960154 1.00 MAPT (0.70) MAPTABCC4ALDH1A1LMNATSHR
SCHEMBL4446966 0.97 MAPT (0.65) MAPTABCC4ALDH1A1LMNATSHR
SCHEMBL11247321 0.91 MAPT (0.87) MAPTABCC4ALDH1A1LMNATSHR
SCHEMBL30197206 0.91 MAPT (0.59) MAPTABCC4ALDH1A1LMNATSHR
SCHEMBL4422106 0.91 MAPT (0.87) MAPTABCC4ALDH1A1LMNATSHR
SCHEMBL30197401 0.91 MAPT (0.59) MAPTABCC4ALDH1A1LMNATSHR
SCHEMBL3136737 0.91 MAPT (0.87) MAPTABCC4ALDH1A1LMNATSHR
SCHEMBL3632217 0.91 MAPT (0.59) MAPTABCC4ALDH1A1LMNATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1797026-A1 (Z)-8-CYCLOHEPTADECENE-1-ONE USED AS A PERFUME Symrise GmbH & Co. KG (DE) 2007-06-20 EP disclosed
WO-2006032665-A1 (Z)-8-CYCLOHEPTADECENE-1-ONE USED AS A PERFUME SYMRISE GMBH & CO. KG (DE) 2006-03-30 WO disclosed